Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pharmacyte Biotech Inc (PMCB)

Pharmacyte Biotech Inc (PMCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharmacyte Biotech Inc 23046 AVENIDA DE LA CARLOTA SUITE 600 LAGUNA HILLS CA 92653 USA

P: 917-595-2850 F: 917-595-2851

Description:

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 79,197
Shares Outstanding, K 1,391,871
Annual Sales, $ 0 K
Annual Net Income, $ -4,070 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,070 K
60-Month Beta 2.10
% of Institutional Shareholders 0.03%
Float, K 1,391,871
% Float 100.00%

Growth:

1-Year Return 36.11%
3-Year Return -51.03%
5-Year Return -57.70%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/12/20
Earnings Per Share ttm 0.00
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

PMCB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -80.57
Return-on-Assets (Before Tax) -71.20
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar